BRIEF-Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In Japan

Reuters
08 Apr
BRIEF-Kalvista Pharmaceuticals Enters Into Licensing Agreement With Kaken Pharmaceutical To Commercialize Sebetralstat For HAE In Japan

April 8 (Reuters) - Kalvista Pharmaceuticals Inc KALV.O:

  • KALVISTA PHARMACEUTICALS ENTERS INTO LICENSING AGREEMENT WITH KAKEN PHARMACEUTICAL TO COMMERCIALIZE SEBETRALSTAT FOR HAE IN JAPAN

  • KALVISTA PHARMACEUTICALS INC - ENTERS LICENSING AGREEMENT WITH KAKEN FOR SEBETRALSTAT IN JAPAN

  • KALVISTA PHARMACEUTICALS INC - UP TO $24 MILLION IN UPFRONT AND MILESTONE PAYMENTS, PLUS ROYALTIES

Source text: ID:nBw5fHhhTa

Further company coverage: KALV.O

(((( Reuters.briefs@thomsonreuters.com ;));))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10